Jacksonville, FL - Data from a pharmacodynamic study suggests that acute coronary syndrome (ACS) patients can be safely switched from maintenance clopidogrel (Plavix, Bristol-Myers ...
April 21, 2010 (Rome, Italy) — There was no overall benefit of reloading clopidogrel prior to PCI in patients already receiving chronic clopidogrel in the ARMYDA-4 RELOAD study, although patients with ...
Sanofi-Aventis:New study provides additional information about an intensified dose-regimen of plavix
The FINANCIAL — On August 30, the OASIS study group will present initial results of the CURRENT-OASIS 7 clinical trial at the European Society of Cardiology congress in Barcelona. Sanofi-aventis ...
NEW YORK, Oct 23 (Reuters) - A small study presented on Monday suggests Eli Lilly and Co.'s experimental blood clot preventer, prasugrel, works faster and could be more effective than the commonly ...
Compared with aspirin monotherapy, maintenance therapy with clopidogrel beyond the initial dual antiplatelet (DAPT) period is associated with a reduction in death, MI, stroke, and other outcomes in ...
In certain patients with mild-to-moderate acute ischemic stroke, dual antiplatelet therapy (DAPT) with aspirin and clopidogrel (Plavix) reduced early neurologic deterioration better than aspirin alone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback